The choice of antibacterial agents to treat Lyme disease should be based on the stage and organ involvement of the infection

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.20, Iss.6, 2004-06, pp. : 14-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review

By  

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 97-104

Bentham Science Publishers

Access to resources Recommend Favorite

Exploration of Structure-Based on Imidazole Core as Antibacterial Agents

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 24, 2013-12 ,pp. : 3118-3130

Bentham Science Publishers

Access to resources Recommend Favorite

Dual Action-Based Approaches to Antibacterial Agents

By  

Current Medicinal Chemistry, Vol. 14, Iss. 13, 2007-06 ,pp. : 1459-1477

Bentham Science Publishers

Access to resources Recommend Favorite

Treat Clostridium difficile infection based on its severity and number of previous episodes

By  

Drugs & Therapy Perspectives, Vol. 28, Iss. 2, 2012-02 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

The Lyme disease controversies continue

By Pavia Charles S  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 10, 2003-10 ,pp. : 1615-1620

Informa Healthcare

Access to resources Recommend Favorite